BAN2401
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BAN2401, covering 2015-06-08 to 2015-06-08. Get the full timeline:
Most recent: Clinical Trial Update: A Randomized, Double-blind, Placebo-controlled Study to Assess Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamic Response of Repeated Intravenous Infusions of BAN2401 in Subjects With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's Disease [Phase 1]